HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balraj Mittal Selected Research

Balraj Mittal Research Topics

Disease

55Neoplasms (Cancer)
07/2019 - 01/2002
31Gallbladder Neoplasms (Gallbladder Cancer)
01/2020 - 02/2004
18Carcinogenesis
11/2014 - 01/2007
18Gallstones (Gallstone)
06/2014 - 02/2004
16Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 01/2007
14Cholelithiasis
06/2013 - 08/2004
12Stomach Neoplasms (Stomach Cancer)
11/2014 - 01/2009
11Obesity
09/2018 - 05/2008
9Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 06/2008
9Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2017 - 01/2008
9Breast Neoplasms (Breast Cancer)
01/2016 - 01/2013
7Insulin Resistance
09/2018 - 11/2011
6Inflammation (Inflammations)
09/2017 - 01/2008
6Dyspepsia (Indigestion)
09/2017 - 11/2007
6Migraine Disorders (Migraine)
11/2013 - 01/2010
5Body Weight (Weight, Body)
04/2016 - 07/2002
5Infections
04/2014 - 11/2007
5Carcinoma (Carcinomatosis)
01/2014 - 02/2004
5Epilepsy (Aura)
09/2011 - 08/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2017 - 01/2008
4Esophageal Squamous Cell Carcinoma
11/2014 - 01/2010
4Neoplasm Metastasis (Metastasis)
01/2013 - 01/2008
4Lung Neoplasms (Lung Cancer)
01/2013 - 10/2009
4Gastritis
07/2010 - 03/2008
3Rheumatic Heart Disease (Rheumatic Heart Diseases)
01/2020 - 10/2013
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2016 - 08/2005
3Type 2 Diabetes Mellitus (MODY)
01/2015 - 02/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 01/2010
3Heart Failure
01/2014 - 01/2011
3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
09/2013 - 03/2012
3Chronic Obstructive Pulmonary Disease (COPD)
01/2013 - 06/2011
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2012 - 10/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2010 - 10/2009
3Microsatellite Instability
04/2004 - 01/2002
2Rheumatoid Arthritis
01/2022 - 11/2014
2Neutropenia
10/2015 - 06/2014
2Left Ventricular Dysfunction
05/2015 - 01/2011
2Anemia
06/2014 - 12/2013
2Morbid Obesity
03/2014 - 07/2012
2Lactose Intolerance (Intolerance, Lactose)
09/2013 - 12/2012
2Ischemic Stroke
05/2013 - 01/2011
2Atherosclerosis
05/2013 - 01/2011
2Hypertension (High Blood Pressure)
05/2013 - 07/2005

Drug/Important Bio-Agent (IBA)

21EnzymesIBA
01/2016 - 09/2006
13Proteins (Proteins, Gene)FDA Link
11/2017 - 07/2005
12CholesterolIBA
06/2013 - 01/2004
10DNA (Deoxyribonucleic Acid)IBA
05/2014 - 11/2002
8CytokinesIBA
01/2018 - 01/2007
8LipidsIBA
12/2013 - 01/2004
7MicroRNAs (MicroRNA)IBA
09/2017 - 08/2010
7ApolipoproteinsIBA
05/2016 - 02/2004
7Matrix Metalloproteinases (MMPs)IBA
09/2014 - 07/2008
6Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2013
6XenobioticsIBA
07/2014 - 07/2008
5Insulin (Novolin)FDA Link
01/2017 - 11/2011
5Apolipoproteins E (ApoE)IBA
05/2016 - 07/2005
5TeaIBA
11/2014 - 07/2009
5Estrogens (Estrogen)FDA Link
07/2014 - 01/2012
4NucleotidesIBA
01/2022 - 09/2011
4Interleukin-10 (Interleukin 10)IBA
09/2017 - 01/2007
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2015 - 04/2008
4phospholipase C epsilonIBA
11/2014 - 12/2013
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
06/2014 - 01/2007
4CarcinogensIBA
04/2014 - 01/2005
4Glutathione Transferase (Glutathione S-Transferase)IBA
12/2013 - 01/2005
4Immunoglobulin G (IgG)IBA
08/2012 - 11/2007
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 - 01/2009
3AdiponectinIBA
01/2017 - 04/2013
3Genetic Markers (Genetic Marker)IBA
02/2016 - 11/2002
3Hormones (Hormone)IBA
01/2015 - 06/2014
3Environmental CarcinogensIBA
06/2014 - 07/2009
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2013 - 08/2010
3Epoxide HydrolasesIBA
07/2013 - 07/2008
3Apolipoproteins B (ApoB)IBA
01/2013 - 02/2004
3NRH - quinone oxidoreductase2IBA
12/2012 - 05/2011
3Toll-Like Receptors (Toll-Like Receptor)IBA
10/2011 - 09/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 03/2008
3gamma-Aminobutyric Acid (GABA)IBA
05/2010 - 07/2002
3UreaseIBA
06/2009 - 11/2007
3Interleukin-6 (Interleukin 6)IBA
01/2009 - 10/2007
3Epidermal Growth Factor (EGF)IBA
06/2008 - 10/2007
3Indicators and Reagents (Reagents)IBA
07/2004 - 01/2003
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 01/2020
23' Untranslated Regions (3' UTR)IBA
12/2016 - 01/2007
2Carrier Proteins (Binding Protein)IBA
06/2016 - 01/2011
2Cardiac MyosinsIBA
06/2016 - 01/2011
2Agouti-Related ProteinIBA
05/2016 - 03/2014
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2016 - 03/2014
2AntigensIBA
02/2016 - 08/2012
2O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
01/2016 - 01/2005
2Angiotensin IIIBA
05/2015 - 08/2010
2ProgesteroneFDA LinkGeneric
07/2014 - 01/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
05/2014 - 01/2014
2Phospholipases (Phospholipase)IBA
01/2014 - 12/2013
2Triglycerides (Triacylglycerol)IBA
04/2013 - 08/2012
2Tissue Inhibitor of MetalloproteinasesIBA
01/2013 - 09/2012

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2016 - 10/2007
10Therapeutics
10/2018 - 01/2003
5Adjuvant Chemotherapy
06/2016 - 01/2013
2Radiotherapy
10/2015 - 10/2007